Valeant (VRX) Controversey is Fascinating, but the Stock is Best Left Alone

When a stock loses around two thirds of its value in just over a month, it is newsworthy. When the reason for the drop is a report from renowned short seller Citron, and well-known fund manager Bill Ackman jumps to the company’s defense and announces that he is increasing his holding, it moves into the realm of